Wound therapy system and related methods therefor

Information

  • Patent Grant
  • 10967106
  • Patent Number
    10,967,106
  • Date Filed
    Friday, May 18, 2018
    6 years ago
  • Date Issued
    Tuesday, April 6, 2021
    3 years ago
Abstract
A portable system for subatmospheric pressure therapy in connection with healing a surgical wound, including a wound dressing dimensioned for positioning relative to a wound bed of a subject and a subatmospheric pressure mechanism dimensioned to be carried or worn by the subject. The subatmospheric pressure mechanism includes a housing having a control unit adapted to draw a vacuum and a canister associated with the housing. The canister has a collection bag disposed therein, which is in fluid communication with the wound dressing to receive exudates from the wound bed. The collection bag is adapted to expand upon receipt of the fluids and has means to release gas from within the collection bag in connection with operation of the control unit. With this arrangement, the canister is attitude independent, i.e., the canister may be positioned on edge, on its side or on its end etc. while still maintaining operation of the control unit. The collection bag may include a hydrophobic vent or material for releasing the gases. In another embodiment, the collection bag comprises a gas permeable material. The collection bag may include one of pleats or bellows.
Description
BACKGROUND
Technical Field

The present disclosure relates to treating an open wound, and, more specifically, relates to a sub-atmospheric wound therapy system including a portable container adapted to maintain the operation of the system regardless of the orientation or positioning of the container.


Background of Related Art

Wound closure involves the migration of epithelial and subcutaneous tissue adjacent the wound towards the center and away from the base of the wound until the wound closes. Unfortunately, closure is difficult with large wounds, chronic wounds or wounds that have become infected. In such wounds, a zone of stasis (i.e. an area in which localized swelling of tissue restricts the flow of blood to the tissues) forms near the surface of the wound. Without sufficient blood flow, the epithelial and subcutaneous tissues surrounding the wound not only receive diminished oxygen and nutrients, but, are also less able to successfully fight microbial infection and, thus, are less able to close the wound naturally. Such wounds have presented difficulties to medical personnel for many years.


Negative pressure therapy also known as suction or vacuum therapy has been used in treating and healing wounds. Application of negative pressure, e.g. reduced or subatmospheric pressure, to a localized reservoir over a wound has been found to assist in closing the wound by promoting blood flow to the area, stimulating the formation of granulation tissue, and encouraging the migration of healthy tissue over the wound. Negative pressure may also inhibit bacterial growth by drawing fluids from the wound such as exudates, which may tend to harbor bacteria. This technique has proven particularly effective for chronic or healing-resistant wounds, and is also used for other purposes such as post-operative wound care.


Generally, negative pressure therapy provides for a wound to be covered to facilitate suction at the wound area. A conduit is introduced through the wound covering to provide fluid communication to an external vacuum source. Atmospheric gas, wound exudates, or other fluids may thus be drawn from the reservoir through the fluid conduit to stimulate healing of the wound. Exudates drawn from the reservoir may be deposited in a collection canister or container.


The systems generally require that the container is maintained in a standing or upright position such that the fluid receiving reservoir within the respective unit may be vented and continue to receive fluid from the patient until the reservoir is full. Accidental tipping or tilting of the bag and/or container may cause the suction to/from the unit to be to be shut-off prior to the fluid receiving reservoir completely filling. This problem is further exaggerated in portable units which may be worn or carried by the subject.


SUMMARY

A portable system for subatmospheric pressure therapy in connection with healing a surgical wound includes a wound dressing dimensioned for positioning relative to a wound bed of a subject and a subatmospheric pressure mechanism dimensioned to be carried or worn by the subject. The subatmospheric pressure mechanism includes a housing having a control unit adapted to draw a vacuum and a canister associated with the housing. The canister has a collection bag disposed therein, which is in fluid communication with the wound dressing to receive exudates from the wound bed. The collection bag is adapted to expand upon receipt of the fluids and has means to release gas from within the collection bag in connection with operation of the control unit. With this arrangement, the canister is attitude independent. i.e., the canister may be positioned on edge, on its side or on its end etc. while still maintaining operation of the control unit. The collection bag may include a hydrophobic vent or material for releasing the gases. In another embodiment, the collection bag comprises a gas permeable material. The collection bag may include one of pleats or bellows.


In another embodiment, the portable system for subatmospheric pressure therapy in connection with healing a surgical wound includes a wound dressing dimensioned for positioning relative to a wound bed of a subject and a subatmospheric pressure mechanism dimensioned to be carried or worn by the subject. The subatmospheric pressure mechanism includes a housing having a control unit adapted to draw a vacuum, a container defining an internal chamber in fluid communication with the vacuum and the wound dressing to receive the wound exudates, a plunger received within the internal chamber and movable during actuation of the control unit and a hydrophobic filter associated with the plunger and permitting escape of gas from the container.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the disclosure and, together with a general description of the disclosure given above, and the detailed description of the embodiment(s) given below, serve to explain the principles of the disclosure, wherein:



FIG. 1 is a side view in partial cross-section of the portable wound therapy system of the present disclosure illustrating the wound dressing and the subatmospheric pressure mechanism;



FIG. 2 is a schematic view illustrating the components of the control unit of the subatmospheric pressure mechanism;



FIG. 3 is a partial cut-away perspective view of an embodiment of a collection canister according to the present disclosure;



FIG. 4 is a cross-sectional side view of an embodiment of an expandable collection bag according to the present disclosure;



FIG. 5 is a perspective side view of another embodiment of an expandable collection bag according to the present disclosure;



FIG. 6 is a perspective side view of yet another embodiment of an expandable collection bag according to the present disclosure;



FIG. 7 is a perspective side view of still another embodiment of an expandable collection bag according to the present disclosure;



FIG. 8 is an interior perspective view of another embodiment of a collection canister according to the present disclosure;



FIG. 9 is an interior perspective view of yet another embodiment of a collection canister according to the present disclosure;



FIG. 10A is a cross-sectional side view of still another embodiment of an collection device according to the present disclosure; and



FIG. 10B is a side view of an intake mechanism of the collection device of FIG. 10A.





DETAILED DESCRIPTION

The wound therapy system of the present disclosure promotes healing of a wound via the use of a wound dressing and a portable subatmospheric pressure mechanism. Generally, the portable subatmospheric pressure mechanism applies subatmospheric pressure to the wound to effectively remove wound fluids or exudates captured by the composite wound dressing, and to increase blood flow to the wound bed and enhance cellular stimulation of epithelial and subcutaneous tissue. The wound therapy system is entirely portable, i.e., it may be worn or carried by the subject such that the subject may be completely ambulatory during the therapy period. The wound therapy system including the subatmospheric pressure mechanism and components thereof may be entirely disposable after a predetermined period of use or may be individually disposable whereby some of the components are reused for a subsequent therapy application.


The wound therapy system of the present disclosure promotes healing of a wound in conjunction with subatmospheric negative pressure therapy. The system may incorporate a variety of wound dressings, subatmospheric pressure sources and pumps, and collection canisters. The attached figures illustrate exemplary embodiments of the present disclosure and are referenced to describe the embodiments depicted therein. Hereinafter, the disclosure will be described by explaining the figures wherein like reference numerals represent like parts throughout the several views.


Referring initially to FIG. 1, wound therapy system 100 according to the present disclosure is illustrated. Wound therapy system 100 includes composite wound dressing 102 and subatmospheric pressure mechanism 104 in fluid communication with the wound dressing 102 through conduit, identified schematically as reference numeral 106.


Wound dressing 102 may includes several components, namely, wound contact layer or member 108, a wound packing member or filler 110 supported by the contact member 108 and outer layer or cover member 112. Wound contact member 108 is adapted to substantially conform to the topography of a wound bed “W”. Wound contact member 108 is substantially porous or perforated to permit exudates to pass from the wound bed “W” through the wound contact member 108. The passage of wound exudates through the wound contact member 108 may be unidirectional such that wound exudates do not flow back to the wound bed “W”. Unidirectional flow may be encouraged by directional apertures formed in contact member 108 or a lamination of materials having absorption properties differing from those of contact member 108. A non-adherent material may be selected such that contact member 108 does not tend to cling to wound bed “W” or surrounding material when it is removed. One exemplary material that may be used as a contact member 108 is sold under the trademark XEROFLOW® by Tyco Healthcare Group LP (d/b/a Covidien).


Wound packing member 110 of wound dressing 102 is intended to absorb and transfer wound fluid and exudates. Wound packing member 110 is conformable to assume the shape of any wound bed “W”. Wound packing member 110 may be treated with agents such as polyhexamethylene biguanide (PHMB) to decrease the incidence of infection, or other medicants to promote healing of the wound. A suitable wound packing material 110 is the antimicrobial dressing sold under the trademark KERLEX® AMD by Tyco Healthcare Group LP (d/b/a Covidien).


Outer member or wound covering 112 encompasses the perimeter of the wound dressing 102 to surround wound bed “W” and to provide a liquid-tight seal around the perimeter “P” of the wound bed “W”. For instance, the sealing mechanism may be any biocompatible adhesive bonded to the perimeter of wound covering 112. Thus, wound covering 112 may act as both a microbial barrier and a fluid barrier to prevent contaminants from entering wound bed “W” and for maintaining the integrity thereof.


Wound covering 112 is typically a flexible material, e.g., resilient or elastomeric, that seals the top of wound dressing 102 to prevent passage of liquids or contamination to and from the wound dressing 102. Wound covering 112 may be formed from a moisture vapor permeable membrane to promote the exchange of oxygen moisture between the wound bed “W” and the atmosphere. A membrane that provides a sufficient moisture vapor transmission rate is a transparent membrane sold under the trade name POLYSKIN® II by Tyco Healthcare Group LP (d/b/a Covidien). A transparent membrane permits an assessment of wound conditions to be made without requiring removal of the wound covering 112. Alternatively, wound covering 112 may comprise an impermeable membrane or a substantially rigid membrane.


Wound covering 112 may include a port or connector 107 in fluid communication with the interior of wound dressing 102 to facilitate connection of wound dressing 102 to conduit or tubing 106. Conduit 106 defines a fluid flow path leading through wound therapy system 100. Connector 107 may be configured as a rigid or flexible, low-profile component, and may be adapted to receive conduit 106 in a releasable and fluid tight manner. A hollow interior of connector 107 provides fluid communication between conduit 106 and the interior of wound dressing 102. Connector 107 may have a valve 109 built therein, e.g., a one-way, valve to permit exudates to flow in one direction only, i.e., away from wound dressing 102 toward subatmospheric pressure mechanism 104. Connector 107 may be provided as a pre-affixed component of wound dressing 102, as a component of conduit 106, or entirely separate and connected thereto by conventional means. Alternatively, connector 107 may be eliminated if other provisions are made for providing fluid communication between wound dressing 102 and conduit 106.


Conduit 106 extends from subatmospheric pressure mechanism 104 to provide fluid communication between the interior of the wound dressing 102 and vacuum source 118. Any suitable conduit may be used including those fabricated from flexible elastomeric or polymeric materials. Conduit 106 may connect to vacuum source 118 or other system components by conventional air tight means such as friction fit, bayonet coupling, or barbed connectors. The conduit connections may be made permanent, or alternatively a quick-disconnect or other releasable means may be used to provide some adjustment flexibility to the apparatus.


Referring now to the schematic diagram of FIG. 2, in conjunction with FIG. 1, control unit 116 of subatmospheric pressure mechanism 104 will be discussed. Control unit 116 includes vacuum source or pump 118 disposed within housing 117, actuator or motor 120 disposed within housing 117 for activating the vacuum source 118 and power source 122 mounted relative to housing 117. Vacuum source or pump 118 generates or otherwise provides negative pressure to wound therapy system 100. Vacuum source or pump 118 may be a pump of the diaphragmatic, peristaltic or bellows type or the like, in which the moving part(s) draw exudates out of the wound bed “W” into the wound dressing 102 by creating areas or zones of decreased pressure e.g., vacuum zones with the wound dressing 100. This area of decreased pressure preferably communicates with the wound bed “W” to facilitate removal of the fluids therefrom and into the absorbent or non-absorbent packing member 110. One suitable peristaltic pump is the Kangaroo Enteral Pump manufactured by Tyco Healthcare Group LP (d/b/a Covidien).


Vacuum source or pump 118 may be a miniature pump or micropump that is biocompatible and adapted to maintain or draw adequate and therapeutic vacuum levels. The vacuum level of subatmospheric pressure achieved may be in the range of about 20 mmHg to about 500 mgHg. In some embodiments, about 75 mmHg and about 125 mmHg is desired or between about 35 mmHg and 75 mmHg may be desired. Vacuum source or pump 118 is actuated by actuator 120 which may be any means known by those skilled in the art, including, for example, AC motors. DC motors, voice coil actuators, solenoids, etc. Actuator 120 may be incorporated within pump 118.


On an exhaust side of vacuum source 118 fluid conduit 106 connects vacuum source 118 to collection canister 132. Conduit 106 may comprise the same material or construction along the entire length of the tubing or may assume an alternate form between vacuum source 118 and canister 132 than between wound dressing 102 and vacuum source 118. In the alternative, it may be separate tubing.


Power source 122 may be disposed within housing 117 or separately mountable to the housing 117. A suitable power source 122 includes alkaline batteries, wet cell batteries, dry cell batteries, nickel cadmium batteries, solar generated means, lithium batteries, NiMH batteries (nickel metal hydride) each of which may be of the disposable or rechargeable variety.


Referring again to FIG. 1, subatmospheric pressure mechanism 104 includes collection canister 132 which collects the exudates removed from the wound bed “W” during therapy through conduit, or tubing, 106. Collection canister 132 is releasably connected to housing 117 of control unit 116. Collection canister 132 may comprise any container suitable for containing wound fluids and is substantially rigid defining an internal chamber 133 in fluid communication with tubing 106. Collection canister 132 may contain an absorbent material to consolidate or contain the wound drainage or debris. In embodiments, at least a portion of collection canister 132 may be transparent to assist in evaluating the color, quality, or quantity of wound exudates. A transparent canister may thus assist in determining the remaining capacity of canister 132 or when the canister 132 should be replaced. In the alternative, collection canister 132 may be relatively flexible.


Turning now to FIG. 3, an embodiment of a collection canister according to the present disclosure is shown generally as collection canister 232. Collection canister 232 includes a substantially rigid housing 204 defining a chamber 204a for receiving a collection bag 202. A cover 206 is configured to engage container 204 to for a sealed chamber 204a. Alternatively, cover 206 may be integrally formed with housing 117. Cover 206 defines an inlet port 206a and an outlet port 206b. Inlet port 206a is in fluid communication with wound dressing 102 and is configured to receive fluid ‘F’ or exudates therefrom. A check valve 212 may be integrally formed with cover 206. Outlet port 206b is operably connected to vacuum source or pump 118. Outlet port 206 includes an extension 207. Extension 207 extends within chamber 204a of container 204. Extension 207 includes a channel 207a or other suitable configuration to ensure suction continues to be provided to chamber 204a as collection bag 202 expands to fill chamber 204a.


Collection bag 202 includes an expandable cavity 202a configured for receiving fluid “F”. Collection bag 202 is constructed with a hydrophobic membrane or other suitable material capable of permitting gases to escape cavity 202a. Alternatively, collection bag 202 may have a hydrophobic vent (not shown). Collection bag 202 is maintained in fluid communication with inlet port 206a. It is envisioned that collection bag 202 may be integrally formed with cover 206.


In operation, suction from pump 118 is provided to chamber 204a of container 204 through outlet port 206b. As a vacuum builds within chamber 204a suction is provided to wound dressing 102 to draw fluid “F” from wound “W”. As fluid “F” flows from wound “W” through inlet port 206a into cavity 202a of collection bag 202, any residual air or other gases in the system pass through collection bag 202. Cavity 202a expands to accommodate fluid “F” as the flow into collection bag 202 continues. Check valve 212 prevents fluid “F” from flowing from cavity 202a back towards wound dressing 102. Alternatively, check valve 212 may be formed on a distal end 106b of conduit 106. Collection bag 202 continues to expand as fluid “F” is drawn from wound “W”. Channel 207a formed in extension 207 of outlet port 206b is configured to permit the continued flow of suction into chamber 204a, thereby allowing collection bag 202 to expand to fill chamber 204a. Once collection bag 202 and/or chamber 204a is filled, cover 206 may be removed and collection bag 202 may be emptied and/or replaced.


With reference now to FIG. 4, an alternate embodiment of a collection bag for use in collection canister 232 is shown as collection bag 202′. Collection bag 202′ defines an expandable cavity 202a′ for receiving fluids. A sealing band 204′ maintains collection bag 202′ in a sealed relationship with patient tube with inlet port 206a of cover 206. A check valve 212′ is positioned on a distal end 106b of a conduit 106 to prevent back flow of fluid from collection bag 202′ into conduit 106.


Collection bag 202′ includes a bulb-shaped container constructed of rubber, polymer or other expandable material. As noted above, collection bag 202′ defines an expandable cavity 202a′. Collection bag 202′ further includes a hydrophobic plug 203′ for releasing gas from within cavity 202a′. As fluid “F” flows from conduit 106 through check valve 212′ and into cavity 202a′ of collection bag 202′, collection bag 202′ expands to accommodate the additional fluid. Any gas trapped within cavity 202a′ may be vented through hydrophobic plug 203′. Collection bag 202′ may be removed from conduit 106 and discarded as necessary. It is envisioned that collection bag 202′ may be reused. Collection bag 202′ may optionally include a tie, draw string or other suitable closure device for sealing cavity 202a′.


Turning to FIG. 5, an alternate embodiment of a collection bag of the present disclosure is shown generally as collection bag 302. Collection bag 302 includes a pleated container constructed of a hydrophobic material, e.g. TYVEK. This construction permits any air or other gases trapped with the collection system to pass through collection bag 302 while collecting fluid “F” (FIG. 3) therein. Collection bag 302 defines an expandable cavity 302a for receiving fluids. In one embodiment, collection bag 302 is preferably configured to expand to fill chamber 204a of collection canister 232. Collection bag 302 may further include a window 303 for viewing the contents of cavity 302a. As fluid enters cavity 302a of collection bag 302, pleats 301 formed in collection bag 302 expand to increase the capacity of cavity 302a and accommodate the additional fluid.


With reference now to FIG. 6, another embodiment of a collection bag of the present disclosure is shown as collection bag 402. Collection bag 402 is constructed of hydrophobic material and includes accordion-like folds 401. Folds 401 are configured to expand as collection bag 402 fills with fluid “F” (FIG. 3).


Turning now to FIG. 7, yet another embodiment of a collection bag is shown generally as collection bag 502. Collection bag 502 is constructed from hydrophobic material that is rolled. Collection bag 502 may include a window (not shown) for viewing the contents therein.


Turning now to FIG. 8, another embodiment of the present disclosure is shown generally as collection device 600. Collection device 600 includes a container 604 defining a first chamber 606 in fluid communication with a second chamber 608 separated by a divider 607. Container 604 further includes an inlet port 604a in fluid communication with first chamber 606 and one or more outlet ports 604b in fluid communication with the second chamber 608. Inlet port 604a is operably connected to conduit 106′. Conduit 106′ may include a check valve (not shown). Outlet ports 604b are operably connected to a source of suction not shown.


A plunger 610 is retained within second chamber 608 of container 604. Plunger 610 is a substantially planar member including a hydrophobic membrane 612 and a seal 214a extending about a perimeter 214 of plunger 610. Plunger 610 is configured to be advanced in the direction of arrow A as suction is applied to outlet ports 604b and air is removed from within second chamber 608. Alternatively, it is envisioned that plunger 610 may be attached to an advancement mechanism, including hydraulic, pneumatic and motorized cylinder, for advancing plunger 610. Movement of plunger 610 towards outlets 604b (direction of arrow “A”) creates a vacuum in first chamber 606. The vacuum created in first chamber 606 provides suction to conduit 106′. As plunger 610 is drawn towards outlets 604b fluid “F” fills first and second chamber 606, 608. Residual air trapped within container 604 and/or conduit 106′ is exhausted though hydrophobic membrane 612. Once first and second chambers 606, 608 are filled, conduit 106′ is disconnected from container 604. Collection device 600 may include a valve or other mechanism (not shown) for draining container 604. Alternatively, collection device 600 may be discarded.


Turning now to FIG. 9, another embodiment of the present disclosure is shown generally as collection device 700. Collection device 700 is substantially similar to collection device 600 and includes a container 704 having a first chamber 706 in fluid communication with a second chamber 708. First and second chambers 706, 708 are separated by a divider. An inlet port 704a fluidly communicates conduit 106′ with first chamber 706. An outlet port 704b fluidly communicates second chamber 708 with a vacuum source (not shown). A plunger 710 is received within first chamber 706. Plunger 710 includes a hydrophobic membrane 212. Plunger 710 is configured to create a vacuum in first chamber 706 as plunger 710 is advanced in the direction of arrow “B”. The vacuum in first chamber 706 causes fluid “F” to be drawn through conduit 106′. Once first chamber 706 is filled, conduit 106′ is disconnected from container 704. Collection device 700 may include a valve or other mechanism (not shown) for draining container 704. Alternatively, collection device 700 may be discarded.


With reference now to FIGS. 10A and 10B, an alternate embodiment of the present disclosure is shown generally as collection canister 800. Collection device 800 includes a container 804 having a cover 806 and defining a substantially sealed chamber container 804a. An inlet port (not shown) may be formed in container 804 and/or cover 806. Cover 806 further includes an outlet port 806b configured for operable connection with a vacuum source. Cover 806 further includes a flange 807 extending inwardly from outlet port 806b. An intake mechanism 810 extends from flange 807 and is in fluid communication with outlet port 806b.


Intake mechanism 810 includes a bellows 812 and a float 814. Bellows 812 may be constructed of silicone or other suitable flexible material. Bellows 812 defines a passageway 812 therethrough in fluid communication with outlet port 806b. Bellows 812 includes openings 813 for receiving air from with chamber 804a. Float 814 may include an air bag, open cell material or other suitable material with a low mass. Float 814 may be affixed to an end of bellows 812. Alternatively, float 814 may be over-molded to bellows 812. Float 814 is configured to maintain at least one of openings 813 formed in bellows 812 above the level of fluid “F” as chamber 804a fills with fluid “F”. Bellows 812 and float 814 are configured such that as container 804 is transported, i.e. tilted or inverted, collection device 800 continues to collect fluid “F”.


Although the illustrative embodiments of the present disclosure have been described herein with reference to the accompanying drawings, it is to be understood that the disclosure is not limited to those precise embodiments, and that various other changes and modifications may be effected therein by one skilled in the art without departing from the scope or spirit of the disclosure.

Claims
  • 1. A system for negative pressure therapy in connection with healing a wound, the system comprising: a wound dressing for positioning relative to a wound;a negative pressure mechanism comprising a housing having a control unit and configured to draw a vacuum; anda canister associated with the housing, the canister comprising: a chamber and a collection bag disposed within the chamber, the collection bag configured to be in fluid communication with the wound dressing to receive exudates from the wound, the collection bag configured to expand upon receipt of the exudates, wherein the collection bag comprises an absorbent material configured to contain exudates removed from the wound.
  • 2. A system for negative pressure therapy in connection with healing a wound, the system comprising: a negative pressure mechanism comprising a first housing and a control unit, wherein the negative pressure mechanism is configured to draw a vacuum;a canister configured to be releasably connected to the negative pressure mechanism, the canister comprising: a container; anda cover, the container configured to engage the cover forming a sealed chamber;an inlet port and an outlet port on the cover of the canister, wherein the inlet port is configured to be in fluid communication with a wound dressing and the outlet port is configured to be in fluid communication with the negative pressure mechanism;a collection bag disposed within the sealed chamber, the collection bag configured to be in fluid communication with the wound dressing through the inlet port to receive exudates removed from a wound, the collection bag adapted to expand upon receipt of the exudates; andan absorbent material configured to contain the exudates removed from the wound.
  • 3. The system of claim 2, wherein the inlet port comprises a check valve configured to prevent fluid from flowing from the canister back to the wound dressing.
  • 4. The system of claim 2, wherein the canister comprises an extension extending within an interior of the canister.
  • 5. The system of claim 2, wherein the inlet port and the outlet port form a fluid pathway through the canister, wherein the exudates are absorbed within the collection bag and gases are configured to pass through the outlet port.
  • 6. The system of claim 1, wherein the chamber comprises a rigid material.
  • 7. The system of claim 1, wherein the chamber comprises a cover portion and a container portion.
  • 8. The system of claim 7, wherein the cover portion and container portion form a sealed chamber.
  • 9. The system of claim 7, wherein the cover portion and container portion are integrally formed.
  • 10. The system of claim 1, wherein the canister comprises an inlet port configured to be in fluid communication with the wound dressing and an outlet port configured to be in fluid communication with the negative pressure mechanism.
  • 11. The system of claim 10, wherein the inlet port comprises a check valve configured to prevent fluid from flowing from the canister back to the wound dressing.
  • 12. The system of claim 1, wherein the canister comprises an extension extending within an interior of the canister.
  • 13. The system of claim 10, wherein the inlet port and the outlet port form a fluid pathway through the canister, wherein exudates are configured to be absorbed within the collection bag and gases are configured to pass through the outlet port.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation application of U.S. application Ser. No. 15/192,605, filed on Jun. 24, 2016, which is a divisional application of U.S. application Ser. No. 14/486,338, filed on Sep. 15, 2014 and issued as U.S. Pat. No. 9,375,521, which is a continuation of U.S. application Ser. No. 13/777,171, filed on Feb. 26, 2013 and issued as U.S. Pat. No. 8,834,452, which is a continuation of and claims priority to U.S. application Ser. No. 12/124,707, filed May 21, 2008 and issued as U.S. Pat. No. 8,414,519.

US Referenced Citations (418)
Number Name Date Kind
730062 Widmer Jun 1903 A
2468445 Hurst Apr 1949 A
3704709 Sorenson et al. Mar 1972 A
3866608 Reynolds et al. Feb 1975 A
3980166 DeFeudis Sep 1976 A
4063556 Thomas et al. Dec 1977 A
4112949 Rosenthal et al. Sep 1978 A
4136696 Nehring Jan 1979 A
4203445 Jessup et al. May 1980 A
4228798 Deaton Oct 1980 A
4266545 Moss May 1981 A
4293609 Erickson Oct 1981 A
4296748 Kurtz et al. Oct 1981 A
4321020 Mital Mar 1982 A
4331147 Armstrong May 1982 A
4373528 Harle Feb 1983 A
4376439 Lauterjung Mar 1983 A
4402687 Denty et al. Sep 1983 A
4429693 Blake et al. Feb 1984 A
4460642 Errede et al. Jul 1984 A
4551141 McNeil Nov 1985 A
4569674 Phillips et al. Feb 1986 A
4573992 Marx Mar 1986 A
4578060 Huck et al. Mar 1986 A
4585397 Crawford et al. Apr 1986 A
4604313 McFarland et al. Aug 1986 A
4642088 Gunter Feb 1987 A
4642093 Harle Feb 1987 A
4655754 Richmond et al. Apr 1987 A
4675010 Siposs et al. Jun 1987 A
4706830 Wareing Nov 1987 A
4738671 Elliott et al. Apr 1988 A
4747844 Elliott May 1988 A
4758238 Sundblom et al. Jul 1988 A
4767417 Boehringer et al. Aug 1988 A
4769019 Kerwin Sep 1988 A
4798578 Ranford Jan 1989 A
4822346 Elliott Apr 1989 A
4826494 Richmond et al. May 1989 A
4828546 McNeil et al. May 1989 A
4832299 Gorton et al. May 1989 A
4840770 Walz et al. Jun 1989 A
4850964 Cotter Jul 1989 A
4865816 Walz et al. Sep 1989 A
4870975 Cronk et al. Oct 1989 A
4889531 D'Antonio et al. Dec 1989 A
4925447 Rosenblatt May 1990 A
4950247 Rosenblatt Aug 1990 A
4955391 Parker et al. Sep 1990 A
4976694 Schreibman Dec 1990 A
4979944 Luzsicza Dec 1990 A
4981474 Bopp et al. Jan 1991 A
4988344 Reising et al. Jan 1991 A
4988345 Reising Jan 1991 A
4990137 Graham Feb 1991 A
5002529 Cunningham Mar 1991 A
5002534 Rosenblatt Mar 1991 A
5053026 Andersen et al. Oct 1991 A
5055198 Shettigar Oct 1991 A
5071104 Witt et al. Dec 1991 A
5073172 Fell Dec 1991 A
5112323 Winkler et al. May 1992 A
5135485 Cohen et al. Aug 1992 A
5141504 Herweck et al. Aug 1992 A
5149325 Telang et al. Sep 1992 A
5156602 Steffler Oct 1992 A
5158533 Strauss et al. Oct 1992 A
5188622 Muller et al. Feb 1993 A
5192439 Roth et al. Mar 1993 A
5219428 Stern Jun 1993 A
5246353 Sohn Sep 1993 A
5254080 Lindsay Oct 1993 A
5275585 Olson Jan 1994 A
5342329 Croquevielle Aug 1994 A
D352463 Kubo Nov 1994 S
5360445 Goldowsky Nov 1994 A
5374257 Drainville et al. Dec 1994 A
5382244 Telang Jan 1995 A
5386735 Langdon Feb 1995 A
5397299 Karwoski et al. Mar 1995 A
5399156 Lindsay Mar 1995 A
5411474 Ott et al. May 1995 A
5458586 Adiletta Oct 1995 A
5466229 Elson Nov 1995 A
5470585 Gilchrist Nov 1995 A
5484428 Drainville et al. Jan 1996 A
5496299 Felix et al. Mar 1996 A
5542939 Onodera et al. Aug 1996 A
5545151 O'Connor et al. Aug 1996 A
5549584 Gross Aug 1996 A
5582601 Wortrich et al. Dec 1996 A
5584824 Gillette et al. Dec 1996 A
5588958 Cunningham et al. Dec 1996 A
5591297 Ahr Jan 1997 A
5630855 Lundbaeck May 1997 A
5636643 Argenta et al. Jun 1997 A
5645081 Argenta et al. Jul 1997 A
5656027 Ellingboe Aug 1997 A
5669892 Keogh et al. Sep 1997 A
5685214 Neff et al. Nov 1997 A
5688516 Raad et al. Nov 1997 A
5693013 Geuder Dec 1997 A
5707173 Cottone et al. Jan 1998 A
5762638 Shikani et al. Jun 1998 A
5776118 Seifert et al. Jul 1998 A
5785700 Olson Jul 1998 A
5787928 Allen et al. Aug 1998 A
5807359 Bemis et al. Sep 1998 A
D400249 Holubar et al. Oct 1998 S
5876387 Killian et al. Mar 1999 A
5882743 McConnell Mar 1999 A
D408625 Barker Apr 1999 S
5944703 Dixon et al. Aug 1999 A
5960837 Cude Oct 1999 A
5997733 Wilbur et al. Dec 1999 A
6010527 Augustine et al. Jan 2000 A
6071267 Zamierowski Jun 2000 A
6075177 Bahia et al. Jun 2000 A
6093230 Johnson, III et al. Jul 2000 A
6099493 Swisher Aug 2000 A
6102205 Greff et al. Aug 2000 A
6142982 Hunt et al. Nov 2000 A
6152902 Christian et al. Nov 2000 A
6168758 Forsberg et al. Jan 2001 B1
6180000 Wilbur et al. Jan 2001 B1
6261276 Reitsma Jul 2001 B1
D449891 Moro Oct 2001 S
6322546 Steg Nov 2001 B1
6352233 Barberich Mar 2002 B1
D456514 Brown et al. Apr 2002 S
6395955 Roe et al. May 2002 B1
6458109 Henley et al. Oct 2002 B1
6468199 Satou et al. Oct 2002 B1
6478774 Balugani et al. Nov 2002 B1
6501002 Roe et al. Dec 2002 B1
D469175 Hall et al. Jan 2003 S
6547255 Donaway et al. Apr 2003 B1
D475132 Randolph May 2003 S
6575333 Raboin Jun 2003 B1
D477869 Vijfvinkel Jul 2003 S
D478659 Hall et al. Aug 2003 S
6620379 Pluk et al. Sep 2003 B1
D481459 Naham Oct 2003 S
6635028 Ielpo et al. Oct 2003 B1
6648862 Watson Nov 2003 B2
6685681 Lockwood et al. Feb 2004 B2
6723430 Kurata et al. Apr 2004 B2
6752794 Lockwood et al. Jun 2004 B2
6755807 Risk, Jr. et al. Jun 2004 B2
6764462 Risk, Jr. et al. Jul 2004 B2
6800074 Henley Oct 2004 B2
6820483 Beckerman Nov 2004 B1
6824533 Risk, Jr. et al. Nov 2004 B2
6856821 Johnson Feb 2005 B2
6868739 Krivitski et al. Mar 2005 B1
6885116 Knirck et al. Apr 2005 B2
D504953 Ryan May 2005 S
6936037 Bubb et al. Aug 2005 B2
6951553 Bubb et al. Oct 2005 B2
6955664 D'Antonio Oct 2005 B2
6979324 Bybordi et al. Dec 2005 B2
D516217 Brown et al. Feb 2006 S
7004915 Boynton et al. Feb 2006 B2
D522657 Murphy et al. Jun 2006 S
7066949 Gammons et al. Jun 2006 B2
7108683 Zamierowski Sep 2006 B2
7128735 Weston Oct 2006 B2
7153294 Farrow Dec 2006 B1
D537944 Eda et al. Mar 2007 S
7198046 Argenta et al. Apr 2007 B1
D544092 Lewis Jun 2007 S
7240676 Rutter Jul 2007 B2
D548347 Ichino et al. Aug 2007 S
D551578 Kuriger et al. Sep 2007 S
D565177 Locke et al. Mar 2008 S
7381859 Hunt et al. Jun 2008 B2
7438705 Karpowicz et al. Oct 2008 B2
D580285 Hendrickson et al. Nov 2008 S
D581042 Randolph et al. Nov 2008 S
D581522 Randolph et al. Nov 2008 S
D585137 Onoda et al. Jan 2009 S
7503910 Adahan Mar 2009 B2
D590934 Randolph et al. Apr 2009 S
7524315 Blott et al. Apr 2009 B2
D593676 Locke et al. Jun 2009 S
D594114 Locke et al. Jun 2009 S
7553306 Hunt et al. Jun 2009 B1
7569742 Haggstrom et al. Aug 2009 B2
D602582 Pidgeon et al. Oct 2009 S
D602583 Pidgeon et al. Oct 2009 S
D602584 Pidgeon et al. Oct 2009 S
7604610 Shener et al. Oct 2009 B2
7611500 Lina et al. Nov 2009 B1
7615036 Joshi et al. Nov 2009 B2
7625362 Boehringer et al. Dec 2009 B2
7670323 Hunt et al. Mar 2010 B2
7699823 Haggstrom et al. Apr 2010 B2
7700819 Ambrosio et al. Apr 2010 B2
7708724 Weston May 2010 B2
7722582 Lina et al. May 2010 B2
D617094 Pidgeon et al. Jun 2010 S
D617461 Kaushal et al. Jun 2010 S
7731702 Bybordi et al. Jun 2010 B2
7758554 Lina et al. Jul 2010 B2
7759537 Bishop et al. Jul 2010 B2
7759539 Shaw et al. Jul 2010 B2
7775998 Riesinger Aug 2010 B2
7779625 Joshi et al. Aug 2010 B2
7794450 Blott et al. Sep 2010 B2
D625801 Pidgeon et al. Oct 2010 S
7837673 Vogel Nov 2010 B2
7846141 Weston Dec 2010 B2
D630313 Pidgeon et al. Jan 2011 S
D630725 Pidgeon et al. Jan 2011 S
7862339 Mulligan Jan 2011 B2
7927318 Risk, Jr. et al. Apr 2011 B2
7964766 Blott et al. Jun 2011 B2
7998125 Weston Aug 2011 B2
8021348 Risk, Jr. et al. Sep 2011 B2
8048046 Hudspeth et al. Nov 2011 B2
8061360 Locke et al. Nov 2011 B2
8062272 Weston Nov 2011 B2
8080702 Blott et al. Dec 2011 B2
8100873 Jaeb et al. Jan 2012 B2
8162909 Blott et al. Apr 2012 B2
8172817 Michaels et al. May 2012 B2
8235972 Adahan Aug 2012 B2
8240470 Pidgeon et al. Aug 2012 B2
8246607 Karpowicz et al. Aug 2012 B2
8257327 Blott et al. Sep 2012 B2
8267909 Clementi et al. Sep 2012 B2
8267918 Johnson et al. Sep 2012 B2
8294586 Pidgeon et al. Oct 2012 B2
8308714 Weston et al. Nov 2012 B2
8323264 Weston et al. Dec 2012 B2
8333744 Hartwell et al. Dec 2012 B2
8348910 Blott et al. Jan 2013 B2
8372049 Jaeb et al. Feb 2013 B2
8372050 Jaeb et al. Feb 2013 B2
8414519 Hudspeth Apr 2013 B2
8444392 Turner et al. May 2013 B2
8460255 Joshi et al. Jun 2013 B2
8494349 Gordon Jul 2013 B2
8535283 Heaton et al. Sep 2013 B2
8551061 Hartwell et al. Oct 2013 B2
8556871 Mormino et al. Oct 2013 B2
8569566 Blott et al. Oct 2013 B2
8617129 Hartwell Dec 2013 B2
8622981 Hartwell et al. Jan 2014 B2
8641691 Fink et al. Feb 2014 B2
8679079 Heaton et al. Mar 2014 B2
8747376 Locke et al. Jun 2014 B2
8771259 Karpowicz et al. Jul 2014 B2
8814840 Evans et al. Aug 2014 B2
8814841 Hartwell Aug 2014 B2
8821458 Locke et al. Sep 2014 B2
8834452 Hudspeth Sep 2014 B2
8843327 Vernon-Harcourt et al. Sep 2014 B2
8845603 Middleton et al. Sep 2014 B2
8864748 Coulthard et al. Oct 2014 B2
8974429 Gordon et al. Mar 2015 B2
9019681 Locke et al. Apr 2015 B2
9050399 Hartwell Jun 2015 B2
9205183 Hartwell et al. Dec 2015 B2
9227000 Fink et al. Jan 2016 B2
9320838 Hartwell et al. Apr 2016 B2
9375521 Hudspeth Jun 2016 B2
9408954 Gordon et al. Aug 2016 B2
9561312 Heaton et al. Feb 2017 B2
9636440 Weston et al. May 2017 B2
9642955 Fink et al. May 2017 B2
9974890 Hudspeth May 2018 B2
20020026160 Takahashi et al. Feb 2002 A1
20020145012 Ho Oct 2002 A1
20020156464 Blischak et al. Oct 2002 A1
20030065292 Darouiche Apr 2003 A1
20030093041 Risk, Jr. et al. May 2003 A1
20030097100 Watson May 2003 A1
20030101826 Neubert Jun 2003 A1
20030163101 Say Aug 2003 A1
20030164600 Dunn et al. Sep 2003 A1
20030181850 Diamond et al. Sep 2003 A1
20030212357 Pace Nov 2003 A1
20030235635 Fong et al. Dec 2003 A1
20040006321 Cheng et al. Jan 2004 A1
20040054338 Bybordi Mar 2004 A1
20040064132 Boehringer et al. Apr 2004 A1
20040087918 Johnson, III et al. May 2004 A1
20040102743 Walker May 2004 A1
20040116551 Terry Jun 2004 A1
20040122383 Romano et al. Jun 2004 A1
20040153029 Blischak et al. Aug 2004 A1
20040167482 Watson Aug 2004 A1
20040180093 Burton et al. Sep 2004 A1
20040193218 Butler Sep 2004 A1
20040233631 Lord Nov 2004 A1
20040260230 Randolph Dec 2004 A1
20050070858 Lockwood et al. Mar 2005 A1
20050124966 Karpowicz et al. Jun 2005 A1
20050144711 Valadez et al. Jul 2005 A1
20050166683 Krivitski et al. Aug 2005 A1
20050187528 Berg Aug 2005 A1
20050209560 Boukhny et al. Sep 2005 A1
20050248045 Anthony Nov 2005 A1
20060009744 Erdman et al. Jan 2006 A1
20060029675 Ginther Feb 2006 A1
20060059980 Matsubara et al. Mar 2006 A1
20060129137 Lockwood et al. Jun 2006 A1
20060144440 Merkle Jul 2006 A1
20060149171 Vogel et al. Jul 2006 A1
20060280650 Wong et al. Dec 2006 A1
20070016152 Karpowicz et al. Jan 2007 A1
20070021697 Ginther et al. Jan 2007 A1
20070027433 Garcia et al. Feb 2007 A1
20070032741 Hibner et al. Feb 2007 A1
20070032763 Vogel Feb 2007 A1
20070055209 Patel et al. Mar 2007 A1
20070078444 Larsson Apr 2007 A1
20070118096 Smith et al. May 2007 A1
20070135779 Lalomia et al. Jun 2007 A1
20070141128 Blott et al. Jun 2007 A1
20070179460 Adahan Aug 2007 A1
20070180904 Gao Aug 2007 A1
20070219513 Lina et al. Sep 2007 A1
20070219532 Karpowicz et al. Sep 2007 A1
20070219535 Phung et al. Sep 2007 A1
20070233022 Henley et al. Oct 2007 A1
20070244451 Romano et al. Oct 2007 A1
20070260226 Jaeb et al. Nov 2007 A1
20080011667 Ruschke Jan 2008 A1
20080015526 Reiner et al. Jan 2008 A1
20080033400 Holper et al. Feb 2008 A1
20080051708 Kumar et al. Feb 2008 A1
20080071234 Kelch et al. Mar 2008 A1
20080071235 Locke et al. Mar 2008 A1
20080082040 Kubler et al. Apr 2008 A1
20080082077 Williams Apr 2008 A1
20080108977 Heaton et al. May 2008 A1
20080125697 Gao May 2008 A1
20080125698 Gerg et al. May 2008 A1
20080132855 Romano et al. Jun 2008 A1
20080183233 Koch et al. Jul 2008 A1
20080200905 Heaton et al. Aug 2008 A1
20080234641 Locke et al. Sep 2008 A1
20080243096 Svedman Oct 2008 A1
20080281281 Meyer et al. Nov 2008 A1
20090005746 Nielsen et al. Jan 2009 A1
20090043268 Eddy et al. Feb 2009 A1
20090101219 Martini et al. Apr 2009 A1
20090157016 Adahan Jun 2009 A1
20090204049 Lee Aug 2009 A1
20090227969 Jaeb et al. Sep 2009 A1
20090234306 Vitaris Sep 2009 A1
20090234309 Vitaris et al. Sep 2009 A1
20090240185 Jaeb et al. Sep 2009 A1
20090240218 Braga et al. Sep 2009 A1
20090254066 Heaton Oct 2009 A1
20090275922 Coulthard et al. Nov 2009 A1
20090312725 Braga Dec 2009 A1
20100022990 Karpowicz et al. Jan 2010 A1
20100030132 Niezgoda et al. Feb 2010 A1
20100036333 Schenk, III et al. Feb 2010 A1
20100042059 Pratt et al. Feb 2010 A1
20100121257 King May 2010 A1
20100126268 Baily et al. May 2010 A1
20100145289 Line et al. Jun 2010 A1
20100211030 Turner et al. Aug 2010 A1
20100268179 Kelch et al. Oct 2010 A1
20100280435 Raney et al. Nov 2010 A1
20100280536 Hartwell Nov 2010 A1
20100305490 Coulthard et al. Dec 2010 A1
20100324510 Andresen et al. Dec 2010 A1
20110028918 Hartwell Feb 2011 A1
20110054421 Hartwell Mar 2011 A1
20110054810 Turner Mar 2011 A1
20110063117 Turner Mar 2011 A1
20110066110 Fathallah et al. Mar 2011 A1
20110077605 Karpowicz et al. Mar 2011 A1
20110092958 Jacobs Apr 2011 A1
20110112493 Koch et al. May 2011 A1
20110130712 Topaz Jun 2011 A1
20110172615 Greener Jul 2011 A2
20110172616 Hartwell et al. Jul 2011 A1
20110251569 Turner et al. Oct 2011 A1
20110295220 Heaton et al. Dec 2011 A1
20110313375 Michaels Dec 2011 A1
20120001762 Turner et al. Jan 2012 A1
20120035560 Eddy et al. Feb 2012 A1
20120041399 Blott et al. Feb 2012 A1
20130090613 Kelch et al. Apr 2013 A1
20130090615 Jaeb et al. Apr 2013 A1
20130102979 Coulthard et al. Apr 2013 A1
20130116635 Fleischmann May 2013 A1
20130138054 Fleischmann May 2013 A1
20130144235 Augustine et al. Jun 2013 A1
20130338614 Heaton et al. Dec 2013 A1
20140100538 Hartwell Apr 2014 A1
20140100539 Coulthard et al. Apr 2014 A1
20140155849 Heaton et al. Jun 2014 A1
20140163491 Schuessler Jun 2014 A1
20140188061 Locke et al. Jul 2014 A1
20140200535 Locke et al. Jul 2014 A1
20140236106 Locke et al. Aug 2014 A1
20140276490 Locke et al. Sep 2014 A1
20140276491 Luckemeyer et al. Sep 2014 A1
20140276497 Robinson Sep 2014 A1
20140309601 Hall et al. Oct 2014 A1
20140320283 Lawhorn Oct 2014 A1
20150073363 Kelch et al. Mar 2015 A1
20150343122 Hartwell Dec 2015 A1
20160144081 Wiesner May 2016 A1
20160151547 Hartwell et al. Jun 2016 A1
20160184498 Jaeb et al. Jun 2016 A1
20160331877 Braga et al. Nov 2016 A1
20180318474 Breitweiser et al. Nov 2018 A1
20180353352 Fink et al. Dec 2018 A1
20190009008 Hartwell Jan 2019 A1
20190060532 Hartwell et al. Feb 2019 A1
Foreign Referenced Citations (45)
Number Date Country
2623320 Jul 2004 CN
39 16 648 Sep 1990 DE
43 12 852 Oct 1993 DE
0 358 302 Mar 1990 EP
1 476 217 Mar 2008 EP
2 079 507 Jul 2009 EP
2 248 546 Nov 2010 EP
2 687 245 Jan 2014 EP
2 711 034 Mar 2014 EP
2 305 325 Apr 2014 EP
2 345 437 Apr 2014 EP
1415096 Nov 1975 GB
2235877 Mar 1991 GB
2418738 Apr 2006 GB
2000-202022 Jul 2000 JP
WO 198700439 Jan 1987 WO
WO 199605873 Feb 1996 WO
WO 199619335 Jun 1996 WO
WO 2003022333 Mar 2003 WO
WO 2003053346 Jul 2003 WO
WO 2003074106 Sep 2003 WO
WO 2003101508 Dec 2003 WO
WO 2004060225 Jul 2004 WO
WO 2005105179 Nov 2005 WO
WO 2005123170 Dec 2005 WO
WO 2006052745 May 2006 WO
WO 2006052839 May 2006 WO
WO-2007087808 Aug 2007 WO
WO-2007087809 Aug 2007 WO
WO 2008036344 Mar 2008 WO
WO 2008036360 Mar 2008 WO
WO 2008039223 Apr 2008 WO
WO 2008039314 Apr 2008 WO
WO 2008048481 Apr 2008 WO
WO 2008049029 Apr 2008 WO
WO 2009004289 Jan 2009 WO
WO 2009077722 Jun 2009 WO
WO 2009086580 Jul 2009 WO
WO 2009124100 Oct 2009 WO
WO 2009151645 Dec 2009 WO
WO 2010017484 Feb 2010 WO
WO 2010039481 Apr 2010 WO
WO 2014113504 Jul 2014 WO
WO 2014107285 Sep 2014 WO
WO 2014143488 Sep 2014 WO
Non-Patent Literature Citations (10)
Entry
U.S. Appl. No. 14/019,932, filed Sep. 6, 2013, Hartwell.
U.S. Appl. No. 14/486,338, filed Sep. 15, 2014, Hudspeth et al.
U.S. Appl. No. 14/878,975, filed Oct. 8, 2015, Wudyka.
U.S. Appl. No. 15/493,058, filed Apr. 20, 2017, Fink et al.
U.S. Appl. No. 29/574,909, filed Aug. 19, 2016, Bjelovuk et al.
U.S. Appl. No. 29/574,925, filed Aug. 19, 2016, Bjelovuk et al.
The American Heritage® Science Dictionary, definition of “Evaporation”, Copyright © 2005, in 3 pages.
Huntleigh Healthcare, “Negative Pressure Positive Outcomes” WoundASSIST TNP Console and Canister Brochure, 2007, in 6 pages.
“Vivano—Product application description,” Hartmann Vivano, accessed Feb. 28, 2013. URL: http://www.vivanosystem.info/20809.php.
KCI, “V.A.C. Freedom User's Guide”, May 2002, in 16 pages.
Related Publications (1)
Number Date Country
20180333521 A1 Nov 2018 US
Divisions (1)
Number Date Country
Parent 14486338 Sep 2014 US
Child 15192605 US
Continuations (3)
Number Date Country
Parent 15192605 Jun 2016 US
Child 15984077 US
Parent 13777171 Feb 2013 US
Child 14486338 US
Parent 12124707 May 2008 US
Child 13777171 US